Stay updated on Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The clinical trial record for pembrolizumab in advanced small bowel adenocarcinoma is displayed, with study details, participant criteria, locations, outcome measures, and a study protocol document.
    Difference
    53%
    Check dated 2026-11-09T13:59:30.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.8.0 instead of v3.7.2. The study record still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:50:32.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A sitewide NIH announcement banner appears above the study record, describing a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study content remains a 403 error page.
    Difference
    1%
    Check dated 2026-10-26T14:29:46.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:52:21.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:57:53.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study record content. This indicates a permission issue rather than an update to the study information.
    Difference
    19%
    Check dated 2026-09-21T22:12:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.